Home
/
Minerva Neurosciences, Inc.
/
Financials
/
Quarterly
Minerva Neurosciences, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Minerva Neurosciences, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2021
Sep 30, 2020
$41.18M
Nov 8, 2021
Q2
2021
Jun 30, 2020
$41.18M
Aug 2, 2021
Q3
2018
Sep 30, 2018
$0
Nov 5, 2018
Q2
2018
Jun 30, 2018
$0
Aug 2, 2018
Q1
2018
Mar 31, 2018
$0
May 3, 2018
Q3
2017
Sep 30, 2017
$0
Nov 6, 2017
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2021
Sep 30, 2021
$0
Nov 8, 2021
Q2
2021
Jun 30, 2021
$0
Aug 2, 2021
Q1
2021
Mar 31, 2021
$0
May 12, 2021
Q3
2020
Sep 30, 2020
$0
Nov 2, 2020
Q2
2020
Jun 30, 2020
$0
Aug 3, 2020
Q1
2020
Mar 31, 2020
$0
May 4, 2020
Q3
2019
Sep 30, 2019
$0
Nov 4, 2019
Q2
2019
Jun 30, 2019
$0
Aug 5, 2019
Q1
2019
Mar 31, 2019
$0
May 6, 2019
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.74M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($3.26M)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($3.26M)
Nov 5, 2025
Q2
2025
Mar 31, 2025
($3.75M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($3.75M)
May 13, 2025
Q3
2025
Mar 31, 2025
($3.75M)
Nov 5, 2025
Q3
2025
Sep 30, 2024
$22.51M
Nov 5, 2025
Q2
2025
Jun 30, 2024
($8.23M)
Aug 14, 2025
Q3
2025
Jun 30, 2024
($8.23M)
Nov 5, 2025
Q1
2025
Mar 31, 2024
($8.57M)
May 13, 2025
Q2
2025
Mar 31, 2024
($8.57M)
Aug 14, 2025
Q3
2025
Mar 31, 2024
($8.57M)
Nov 5, 2025
Q3
2024
Sep 30, 2023
($7.82M)
Nov 5, 2024
Q2
2024
Jun 30, 2023
($6.19M)
Aug 6, 2024
Q3
2024
Jun 30, 2023
($6.19M)
Nov 5, 2024
Q1
2024
Mar 31, 2023
($6.97M)
May 1, 2024
Q3
2024
Mar 31, 2023
($6.97M)
Nov 5, 2024
Q2
2024
Mar 31, 2023
($6.97M)
Aug 6, 2024
Q3
2023
Sep 30, 2022
($6.90M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($8.72M)
Aug 1, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.84M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($3.37M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($3.90M)
May 13, 2025
Q3
2025
Sep 30, 2024
($4.37M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
($6.28M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($6.68M)
May 13, 2025
Q3
2024
Sep 30, 2023
($6.08M)
Nov 5, 2024
Q2
2024
Jun 30, 2023
($4.52M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($5.35M)
May 1, 2024
Q3
2023
Sep 30, 2022
($5.21M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($6.97M)
Aug 1, 2023
Q1
2023
Mar 31, 2022
($7.99M)
May 15, 2023
Q3
2022
Sep 30, 2021
($7.52M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($8.96M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($7.51M)
May 4, 2022
Q3
2021
Sep 30, 2020
($8.09M)
Nov 8, 2021
Q2
2021
Jun 30, 2020
$29.51M
Aug 2, 2021
Q1
2021
Mar 31, 2020
($12.27M)
May 12, 2021
Q3
2020
Sep 30, 2019
($14.28M)
Nov 2, 2020
Q2
2020
Jun 30, 2019
($12.90M)
Aug 3, 2020